HPGDS and colorectal cancer: In general, it appears that Compound A was able to selectively decrease the expression of several genes in the colorectal cancer cell line responsible for the defenses against ROS including but not limited to several proteins involved in glutathione-homeostasis including peroxiredoxins, glutathione peroxidases, and glutathione S-transferases.